Early-stage breast cancer typically involves surgical resection, adjuvant or neoadjuvant chemotherapy, radiation therapy, hormone therapy for hormone receptor-positive tumors, and targeted therapy for HER2-positive tumors (Bravo et al., 2023; Grant et al., 2024). The gene discussed is ERBB2; the disease is breast cancer.